CCP Approves Hoechst’s Acquisition of Claforan Trademarks
The Competition Commission of Pakistan (CCP) approved on Friday the acquisition of trademarks for the pharmaceutical product Claforan by Hoechst Pakistan Limited from Sanofi Aventis Deutschland GMBH. This acquisition was facilitated through a trademark assignment agreement, marking a significant transaction in Pakistan’s pharmaceutical industry.